When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMGN - ImmunoGen reboots operations after mirvetuximab soravtansine flop
ImmunoGen Inc.
Aimed at extending is cash runway while it conducts another Phase 3 trial for antibody-drug conjugate (ADC) mirvetuximab soravtansine, ImmunoGen (NASDAQ:IMGN) will restructure its business, including the termination of 220 employees.
More news on: ImmunoGen, Inc., Healthcare stocks news,